Working… Menu

A Study Comparing AC0010 and Chemotherapy in Patients With Advanced NSCLC Who Have Progressed Following Prior EGFR TKI

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03058094
Recruitment Status : Withdrawn (Considiering to change the Chemotherapy into Gefitinib)
First Posted : February 20, 2017
Last Update Posted : February 4, 2019
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Information provided by (Responsible Party):
Hangzhou ACEA Pharmaceutical Research Co., Ltd.

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : January 2020